Screener
Rapport Therapeutics, Inc. RAPP Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s invested capital?
- Rapport Therapeutics, Inc. (RAPP) reported invested capital of $369.42M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s invested capital changed year-over-year?
- Rapport Therapeutics, Inc.'s invested capital increased by 67.7% year-over-year, from $220.31M to $369.42M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s invested capital?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s invested capital has grown at a 117.6% compound annual growth rate (CAGR), from -$93.66M to $443.49M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Rapport Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude